Perspectives

Nature Reviews Genetics 5, 311-315 (April 2004) | doi:10.1038/nrg1320

Science and societyShaping science policy in the age of genomics

Richard R. Sharp1, Michael A. Yudell2 & Samuel H. Wilson3  About the authors

Top

The potential of genomic technologies for improving the diagnosis and treatment of many human diseases will not be fully realized until several ethical, legal and social issues are addressed by effective science policy. We believe that more widespread public debate and subsequent policy action are urgently required. Here, we discuss several mechanisms by which this might occur. We propose an independent genome policy organization as an additional approach to promoting informed science policy in the age of genomics.

Author affiliations

  1. Richard Sharp is at the Center for Medical Ethics and Health Policy, Baylor College of Medicine, Houston, Texas 77030, USA.
  2. Micheal Yudell is at the Center for the History and Ethics of Public Health, Mailman School of Public Health, Department of Sociomedical Sciences, Columbia University, 722 West 168th Street, New York, New York 10032, USA.
  3. Samuel Wilson is at the National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, North Carolina 22709-2233, USA.
    Email: may16@columbia.edu

MORE ARTICLES LIKE THIS

These links to content published by NPG are automatically generated.

NEWS AND VIEWS

Is there a future for research?

Nature News and Views (20 Jul 1989)

Extra navigation

Subscribe

Subscribe to Nature Reviews Genetics

Search PubMed for

Open Innovation Challenges

Advertisement